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ABSTRACT 
A new alkaloid, (10E, 12E)-9-ureidooctadeca-10, 12-dienoic acid, named 
oleraurea (1) and 10 known compounds, p-hydroxybenzaldehyde (2), 
p-hydroxybenzoic acid (3), p-hydroxyacetophenone (4), benzamide (5), 
(E)-p-coumaramide (6), (E)-ferulamide (7), soyalkaloid A (8), β- 
carboline-3-carboxylic acid (9), 2, 3, 4, 9-tetrahydro-1H-pyrido [3, 4-b] 
indole-3-carboxylic acid (10), (1S, 3S)-1-methyl-1, 2, 3, 4-tetrahydro- 
β-carboline-3-carboxylic acid (11) were obtained from Portulaca oleracea L., in 
which, compounds 4, 5, 8–11 were isolated from the plant for the first time. The 
structure of the compound 1 was identified using spectroscopic methods 
including 1D and 2D NMR, HR-ESI-TOFMS. The compounds 1, 5–11 presented 
anticholinesterase activities, but the P. oleracea extract (POE) presented very 
low anticholinesterase activity. 
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1. Introduction 
Portulaca oleracea L. is succulent annual herb belonging to the family 
Portulacaceae, order Caryophyllales in phytochemical taxonomy (Lei et al. 
2015), which is widely distributed in the tropical and subtropical areas in the 
world (Zhou et al. 2015). P. oleracea is name  ‘ a Chi Xian’ because i s lea es 
seem like  ee h of ho se an   as e likes ama an h, also, name  ‘Chan   hou Cai’ 
because of its cold resistance, tenacious vitality and prolonging lifespan. 
 
 
Figure 1. Chemical structures of compounds isolated from P. oleracea 
 
P. oleracea is  e a  e  as  he plan  of ‘homolo y of foo  an  me icine’   ian  e  
al. 2014) because of its safety for daily consumption as a vegetable (Yen et al. 
2001) and its many health effects, i.e. anti-inflammatory (Li et al. 2016), 
antioxidant (Yang et al. 2009), antimicrobia (Nayaka et al. 2014), antidiabetics 
(Li et al. 2009), anti-tumor (Zhao et al. 2013), and the effects should mainly 
attribute to the constituents in P. oleracea, such as alkaloids (Li et al. 2016; Xu 
et al. 2016; Li et al. 2017; Zhao et al. 2017), flavonoids (Xu et al. 2006), terpe-
noids (Xin et al. 2010), organic acids (Wang et al. 2017), phenolic compounds 
(Erkan 2012), cerebrosides (Zheng et al. 2014). 
Concerning alkaloids have a wide range of structural diversity and biological 
activities, for examples, some alkaloids are anticholinesterase (AChE) inhibitors, 
which a e  he useful pa hway fo  cu in   he Alzheime ’s  isease  AD   Richa   e  
al. 2010), in this paper we investigated the alkaloids in P. oleracea extract (POE) 
and evaluated their AChE inhibitory activities. A new alkaloid, (10E, 
12E)-9-ureidooctadeca-10, 12-dienoic acid, named oleraurea, together with 10 
known compounds were finally obtained (Figure 1). In addition, the 
anticholinesterase activities of the 11 compounds and the POE were studied by 
Ellman’s colo ime  ic me ho  wi h some mo ifica ions. The compoun s 1, 8–11 
presented higher anticholinesterase activities among the pure compounds with 
IC
50
 between 62.22–67.65 μM, conversely, the POE with IC
50 
of 257.09 ± 5.90 
μM nearly presented no anticholinesterase activity, and eserine with IC
50
 of 
29.74 ± 0.14 μM was to be the positive control in the study. 
 
2. Results and discussion  
2.1. Structure elucidation  
Compound 1 was a white power, which presented a dark spot at UV 254 nm and 
a blue fluoresce at UV 365 nm. The UV (MeOH) λmax: 226 nm (Figure S4) and IR: 
3442, 1650, 1606 cm
−1
 (Figure S5). Its molecular formula was C19H34N2O3 with 4 
degrees of unsaturation which was deduced from the 
1
H NMR, 
13
C NMR 
spectrum data (Table S1) and the HR-ESITOF-MS ion peaks at m/z 339.2650 [M + 
H]
+
 (calc for: 339.2643), m/z 699.5030 (2 M + Na)
+ 
(calc for: 699.5032), m/z 
337.2512 [M–H]
–
 (calc for: 337.2496). The HR-ESI-TOF-MS showed a strong ion 
peak at m/z 279.2518 (M
+
－HNCONH
2 
+ H)
+
 (Figure S3.1), belonging to octadec-
adienoic acid (Huang et al. 2004). Therefore, δ
C
 175.3 in 
13
C NMR spectrum of 
compound 1 was assigned to carboxyl group. The 
1
H NMR spectrum (Figure S6) 
proved the presence of the methyl that gave rise to signals at δ
H
 0.84 (t, 3H, J = 
6.7 Hz); the methylenes that gave rise to signals at δ
H
 1.22 (m, 10H, overlapped), 
1.26 (m, 2H), 1.33 (m, 2H), 1.36 (m, 2H), 1.46 (m, 2H), 2.01 (q, 2H, J = 14.4 Hz) 
and 2.14 (m, 2H); the methine group that gave rise to signals at δ
H
 4.02 (m, 1H); 
 he ‘－HNCONH
2
’  ha   a e  ise  o si nals a  δ
H
 5.32 (2H, br) and 5.90 (d, 1H, J = 
8.5 Hz); the olefinic methines that gave rise to signals at δ
H 
5.47 (m, 1H), 5.60 
(m, 1H) and 5.99 (d, 2H, J = 14.1 Hz, overlapped). The 
13
C NMR spectrum (Table 
S1) (Figure S7) and DEPT spectrum (Figure S8) revealed 19 carbon resonances, 
which include one methyl (δ
C
 13.9), eleven methylenes (δ
C
 21.9, 24.6, 25.3, 
28.4, 28.6, 28.7, 28.8, 30.8, 31.9, 34.1, 35.2), one methine group (δ
C
 50.2), four 
olefinic methines (δ
C
 128.6, 129.9, 133.3, 134.0) and two quaternary carbons (δ
C
 
158.2, 175.3). The 
1
H-
1
H COSY (Figure S2, S9) showed the strong correlations of 
H-2/H-3/H-4/H-5/H-6/H7/H-8/H-9/H-10/H-11/H-12/H-13/H-14/H-15/H-16/H-17 
/H-18, at the same time, the HMBC correlation (Figure S1, S10) showed 
correlations from H-2 to C-1, 3; H-8 to C-7; H-9 to C-10, 11; H-10 to C-12; H-13 to 
C-11; H-14 to C-12, 13, 15, 16; H-15 to C-13, 14, 16, 17; H-16 to C-17; H-17 to 
C-16, 18; H-18 to C-16, 17. Therefore, both 
1
H-
1
H COSY and HMBC confirmed the 
existence of long carbon chain. There is an obvious correlation signal of δ
H
 2.14 
to δ
C
 175.3 in the HMBC spectrum, indicating that a signal at δ
C
 175.3 existed in 
the carbon spectrum. In addition, the downfield chemical shift of methylene 
protons happened because of δ
H 
2.14 connecting with the carboxyl carbon of δ
C 
175.3, and this allowed us to assign δ
H 
2.14/δ
C 
34.1 at C-2. The 
1
H-
1
H COSY 
co  ela ion su  es e   he p esence of ‘－HNCONH
2
’ because of  he  ownfiel  
chemical shifts of H-9 and the correlation from H-9 to NH, and the NOESY 
correlation (Figure S2, S12) from NH to NH
2
, H-8, 9, 10; NH
2
 to NH, H-9 also. 
NOESY spectrum showed that the four olefinic carbons belong to two double 
bonds and were respectively assigned to C-10, 11, 12 and 13, the intensive 
signals leading the adjacent methylene protons shifting to downfield at 31.9 
(position 14) and methine protons at 50.2 (position 9), furthermore, the 
coupling constant (14.4 Hz) confirmed the trans-configuration of two double 
bonds. Thus, the structure of compound 1 was elucidated as (10E, 
12E)-9-ureidooctadeca-10, 12-dienoic acid, named oleraurea.  
By comparison of the 
1
H and 
13
C NMR spectral data with literature, the 10 
known compounds (2–11) were identified, respectively, as 
p-hydroxybenzaldehyde (2) (Kim et al. 2003), p-hydroxybenzoic acid (3) (Wang 
et al. 2000), p-hydroxyacetophenone (4) (Liu et al. 2013), benzamide (5) (Cheng 
et al. 2017), (E)-p-coumaramide (6) (Kokubun et al. 2012), (E)-ferulamide (7) 
(Kokubun et al. 2012), soyalkaloid A (8) (Wang et al. 2016), β-carboline-3-car-
boxylic acid (9) (Tran et al. 2015), 2, 3, 4, 9-tetrahydro-1H-pyrido 
[3,4-b]indole-3-carboxylic acid (10) (Goda et al. 1999), 
(1S,3S)-1-methyl-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid (11) (Brossi et 
al. 1973). 
2.2. Anticholinesterase activity  
AD is the most common form of neurodegenerative disease in the aged and the 
patient have loss of memory, cognitive abilities and obstacle in behavior 
(Mohamed et al. 2011). Currently, the more accepted AD pathology is the 
cholinergic hypothesis and the effective treatment strategy is to inhibit the 
activity of AChE and improve the level of acetylcholine in the brain (Kurt et al. 
2015). Our experiment herein was devoted to search for the effective 
cholinesterase inhibitors. The anticholinesterase activities of the 11 compounds 
and the POE were determined using a microplate assay, and IC
50
 values of the 
11 compounds and the POE were presented in Table S2. The compounds 1, 
5–11 isolated from P. oleracea ranged 1–35 μM exhibited different degree of 
activities against the AChE with IC
50
 values of 62.22 ± 1.02–121.77 ± 0.72 μM far 
less than that of POE with IC
50
 of 257.09 ± 5.90 μM, meaning that the POE 
presented very low anticholinesterase activity which was similar with the results 
of the literature (Boga, et al. 2011). IC
50
 value of positive control eserine was  
29.74 ± 0.14 μM.  
 
3. Experimental  
3.1. General experimental procedures  
The further separation and purity of compounds 1–11 used a Shimadzu Nexera 
X2 UHPLC LC-30A system (Shimadzu, Kyoto, Japan) with a UV 
spectrophotometric detector (SPD-20A), a vacuum degasser (DGU-20A), a 
solvent delivery pump (LC-30AD) and Lab Station software (Shimadzu). The 
analytical column was a Diamonsil C
18 
column (150 mm × 4.6 mm i.d., 5 μm) 
(Dikma Technologies, Bejing, China). The UV spectrum was detected using a 
HITACHI U-3010 spectrophotometer (Hitachi Ltd, Tokyo, Japan). The IR 
spectrum was recorded on an IR 200 spectrophotometer (Thermo Electron 
Corporation, Waltham, MA). The optical rotation was detected on an autopol I 
antomatic polarmeter (Rudolph Research Analytical, Hackettstown, NJ). The 
1
H 
(1D, 2D COSY) and 
13
C (1D, 2D HMBC) NMR spectra were determined using an 
AVANCE 500 MHz instrument (Bruker Corporation, Switzerland) in MeOD and 
DMSO, using TMS as an internal standard. An Agilent 1290 UHPLC system 
coupled to an Agilent 6520 quadrupole-time of flight mass spectrometer 
(Agilent, Waldbronn, Germany) was carried out to reference UHPLC-Q-TOF/MS 
spectra. The acetylcholinesterase inhibitory assay was performed in 96-well 
microplates and determinedusing an Emax precision microplate reader (Nanjing 
defe experiment equipment co. LTD).  
3.2. Plant materials and reagents  
The air-dried aerial parts P. oleracea was collected from Shijiazhuang, Hebei, 
China in June 2014. The plant material was kindly identified by Professor Dr. 
Xixiang Ying. Voucher specimens (No. 20140312) were deposited at School of 
Pharmacy, Liaoning University of Traditional Chinese Medicine. Methanol and 
acetonitrile were all of HPLC grade purchased from Damao Chemical Reagent 
Plant (Tianjin, China). All other reagents were analytical grade provided by 
Jinfeng Chemical Factory (Tianjin, China) and the water was WAHAHA purified 
water (Shenyang, China). Sodium dihydrogen phosphate and disodium 
hydrogen phosphate were purchased from Sinopharm Chemical Reagent Co., 
Ltd. Eserine was provided by Biochempartner. 5, 5-dithiobis-2-nitrobenzoic acid 
(DTNB) was purchased from Shanghai Jinsui Bio-Technology Co., Ltd. 
Acetylthiocholine iodide (ATCI) and AChE were provided by Dalian Meilun 
Biotech Co., Ltd. Polyamide and silica gel (Qingdao Marine Chemical Co., 
Qingdao, China). Sephadex LH-20 and ODS (GE Healthcare, Marlborough, MA) 
were used for column chromatography (CC). TLC was performed on TLC plates 
pre-coated with silica gel GF254 (Qingdao Marine Chemical Co., Qingdao, 
China).  
3.3. Extraction and isolation  
A sample (150 kg) of the air-dried aerial parts P. oleracea was extracted with 
50% ethanol twice under reflux for 2 h each time. The ethanol POE was 
concentrated under reduced pressure to yield a crude POE (21 kg) and then 
subjected to chromatography on a silica-gel (80–100 mesh) column eluted 
sequentially with ethyl acetate and ethanol (1:0, 4:1, 2:1, v/v). The part of 2:1 
was provided (1 kg) after concentrated, then the POE was divided into two 
equal parts, adsorbed on a polyamide resin (80–100 mesh, Taizhou Luqiao Sijia 
Biochemical Plastic Factory, Zhejiang, China) column eluted with equal distilled 
water, 30, 50 and 70% ethanol, respectively. The fractions of 30% ethanol (150 
g) were evaporated and applied to a silica-gel (200–300 mesh, approximately 
2.5 kg) column (8 × 120 cm), eluting sequentially withi isocratic ethyl acetate 
and methanol (5:1, 2:1, 1:2, 1:3, v/v) for further purification to obtain eluates 
1–4. The resulting Fr. 1 (ethyl acetate and methanol 5:1, 14 g) was applied to 
20–40 μm ODS-C
18
 (150 g) column (φ3 × 70 cm) under medium pressure and 
eluted with MeOH-H
2
O (20:80, 40:60, 60:40, 80:20, 100:0, v/v) to obtain 5 
fractions (200 mL each). The fourth was applied to Sephadex LH-20 (150 g) 
column (ϕ2 × 150 cm) using methanol as eluant to obtain a pure mixture. Final 
separation was performed on a UHPLC equipped with an autosampler and 
eluted with the mobile phase consisted of acetonitrile-0.1% formic acid water 
(49:51, v/v), yielding compound 1 (5 mg, purity > 98% with UHPLC, t
R 
13.45 min). 
The eluate 3 was purified with Sephadex LH-20 (150 g) column (ϕ2 × 150 cm) 
and eluted with MeOH, followed by UHPLC preparation using a mobile phase of 
MeOH-H
2
O (15:85), yielding six known compounds, p-hydroxybenzaldehyde (2) 
(18 mg, purity > 98% with UHPLC, t
R 
18.34 min), p-hydroxybenzoic acid (3) (8 
mg, purity > 98% with UHPLC, t
R 
8.17 min), p-hydroxyacetophenone (4) (5 mg, 
purity > 98% with UHPLC, t
R
 17.59 min), benzamide (5) (10 mg, purity > 98% 
with UHPLC, t
R
 11.61 min), (E)-p-coumaramide (6) (7 mg, purity > 98% with 
UHPLC, t
R
 8.04 min) and (E)-ferulamide (7) (4 mg, purity > 98% with UHPLC, t
R 
7.38 min). The eluate 1 was separated by UHPLC and eluted with the mobile 
phase consisted of acetonitrile -0.1% formic acid water (20:80, v/v), yielding five 
known compounds, soyalkaloid A (8) (15 mg, purity > 98% with UHPLC, t
R
 18.12 
min), β-carboline-3-carboxylic acid (9) (6 mg, purity > 98% with UHPLC, t
R
 7.32 
min), 2,3,4,9-tetrahydro-1H-pyrido[3, 4-b]indole-3-carboxylic acid (10) (10 mg, 
purity > 98% with UHPLC, t
R
 5.09 min), 
(1S,3S)-1-methyl-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid (11) (15 mg, 
purity > 98% with UHPLC, t
R 
6.87 min). The flow rate was 1.0 mL/min and the 
column temperature was 40 °C. 
oleraurea (1): white power; [α]20 D + 9.8 (c 0.22, CHCl
3
); UV (MeOH) λmax 226 
nm; IR (KBr) νN–H 3442 cm
−1
, νCH 2932, 2861 cm
−1
, νC=O 1650, 1606 cm
−1
,
 
νCH 1355 
cm
−1
; 
1
H and 
13
C NMR spectroscopic data (DMSO), see Table S1; 
UHPLC-Q-TOF/MS m/z 339.2650 [M + H]
+
 (calcd: 339.2643), m/z 699.5030 (2 M 
+ Na)
+
 (calc for: 699.5032), m/z 337.2512[M–H]
–
 (calc for: 337.2496) 
3.4. Acetylcholinesterase activity assay  
Ace ylcholines e ase ac i i y was  es e  by Ellman’s colo ime  ic me ho  
(Ellman et al. 1961) with some modifications. In the 96-well plates, 140 μL PBS 
(0.1 M, pH = 8.0, containing 0.1 mol/L NaH
2
PO
4
 and Na
2
HPO
4
), 10 μL DTNB (15 
mmol/L), 15 μL AChE (0.2 U/mL) and 20 μL of a serially diluted solution of the 
tested samples were mixed and incubated for 10 min, then added with 10 μL 
ATCI (15 mmol/L) and incubated at 20 °C for 10 min. The absorbance of each 
well was determined at 405 nm using a microplate reader. In the blank group, 
the tested sample was replaced by methanol. The percentage inhibition was 
calculated according to the following formula: inhibition activity (%) = [(blank 
group－test group)/blank group] × 100%. Anticholinesterase activities were 
evaluated by the value of IC
50
.  
 
4. Conclusion  
In the study, a new alkaloid, (10E, 12E)-9-ureidooctadeca-10, 12-dienoic acid, 
along with 10 known compounds were isolated from P. oleracea, in which, 
compounds 4, 5, 8, 9, 10, 11 were isolated from the plant for the first time, and 
compounds 1, 5, 6, 7, 8, 9, 10, 11 exhibited higher anticholinesterase activities 
than that of the POE, suggested that the natural compounds in the P. oleracea 
presented a better pharmacological activities than that the extract, and 
therefore it is interesting to isolate more natural bioactive compounds from P. 
oleracea in the further study. 
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